GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.

Analyse Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OY6
Type
protein
Length
1,166 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activin receptor type-1
EC
2.7.11.30
UniProt
Q04771
Ligands
B4E
Pockets
12 · best druggability 0.76

Structure

x-ray diffraction · 3 distinct chains · 39% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CActivin receptor type-1 (EC 2.7.11.30)protein29138% helix, 22% strandQ04771
BActivin receptor type-1 (EC 2.7.11.30)protein29240% helix, 22% strandQ04771
DActivin receptor type-1 (EC 2.7.11.30)protein29239% helix, 22% strandQ04771

Ligands and binding sites

  • B4E · cyclical inhibitor OD36 · ligand · 4 copies · chains A, B, C, D
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17870.760.8069empty
28040.730.7885B4E
34600.720.8250B4E, EDO
44470.710.8253B4E
53920.700.8249B4E

Interfaces

6 interfaces between chains.

  • A–C · 385 Ų buried · 0 hydrogen bonds · protein-protein
  • A–B · 306 Ų buried · 3 hydrogen bonds · protein-protein
  • B–C · 198 Ų buried · 0 hydrogen bonds · protein-protein
  • B–D · 190 Ų buried · 1 hydrogen bond · protein-protein
  • C–D · 31 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5OY6 · Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36. · the same entry in another collection · chain D against D, TM-score 1.00
  • Q04771 · AlphaFold monomer V2.0 prediction for activin receptor type-1 (Q04771) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.